**Core Concept**
Chronic granulomatous disease (CGD) is a rare genetic disorder characterized by the inability of phagocytic cells to kill certain bacteria and fungi due to a defect in the NADPH oxidase system, leading to a deficiency in superoxide production.

**Why the Correct Answer is Right**
The correct answer is related to the pathophysiology of CGD. The NADPH oxidase system is crucial for the production of superoxide, a key component of the respiratory burst in phagocytic cells. In CGD, the absence or dysfunction of any of the subunits of the NADPH oxidase complex (gp91phox, p22phox, p47phox, p67phox, or p40phox) impairs superoxide production, making phagocytic cells unable to kill certain pathogens.

**Why Each Wrong Option is Incorrect**
**Option A:** This statement about CGD is true, as the disorder is characterized by recurrent life-threatening infections, particularly with catalase-positive bacteria such as Staphylococcus aureus and Aspergillus species.
**Option B:** This statement is also true, as CGD patients often develop granulomatous inflammation in response to chronic infections, leading to tissue damage and organ dysfunction.
**Option C:** This statement is true, as CGD is caused by mutations in the genes encoding the subunits of the NADPH oxidase complex, leading to a deficiency in superoxide production.

**Clinical Pearl / High-Yield Fact**
CGD patients are particularly susceptible to infections with catalase-positive bacteria, which can be treated with antibiotics that are effective against these organisms. However, the underlying defect in NADPH oxidase function requires specific therapeutic approaches, such as interferon-gamma therapy or gene therapy.

**Correct Answer:** D.